Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 12/2019

05.08.2019 | Original Article

Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study

verfasst von: Jacob W. Groenendyk, Parag Shukla, Amit K. Dey, Youssef A. Elnabawi, Milena Aksentijevich, Harry Choi, Leonard D. Genovese, Charlotte L. Harrington, Balaji Natarajan, Aditya Goyal, Aarthi S. Reddy, Justin Rodante, Mohammad Tarek Kabbany, Ahmed Sadek, Mina Al Najafi, Martin P. Playford, Aditya A. Joshi, Mark A. Ahlman, Joel M. Gelfand, David A. Bluemke, Nehal N. Mehta

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The contribution of inflammation to the incidence of cardiovascular disease (CVD) has been increasingly recognized in recent years. We investigated the relationship of aortic vascular uptake of 18F-FDG by PET/CT and aortic wall thickness (AWT) by MRI in psoriasis, a chronic inflammatory disease with increased incidence of CVD. One hundred sixty-five patients with plaque psoriasis participated in an ongoing longitudinal cohort study. Subclinical atherosclerosis was assessed as aortic uptake of 18F-FDG by PET/CT reported as target-to-background ratio (TBR) and AWT by MRI reported as maximal thickness.

Results

Patients with psoriasis were middle aged, predominantly male, and had mild CV risk by traditional risk factors. Psoriasis severity as measured by PASI score was a notable determinant of AWT (ρ = 0.20, p = 0.01). Moreover, aortic vascular uptake of 18F-FDG associated with AWT by MRI at baseline in unadjusted analysis (β = 0.27 p = 0.001) and following adjustment for traditional cardiovascular risk factors, waist-to-hip ratio, and statin use (β = 0.21 p = 0.01). Finally, following 1 year of psoriasis treatment, a decrease in aortic vascular uptake of 18F-FDG was associated with a reduction in AWT in fully adjusted models (β = 0.33, p = 0.02).

Conclusion

In conclusion, we demonstrate that psoriasis severity and aortic vascular uptake of 18F-FDG in the aorta were associated with AWT. Following treatment of psoriasis, a decrease in aortic vascular uptake of 18F-FDG was associated with a reduction in AWT at 1 year. These findings suggest that aortic vascular uptake of 18F-FDG is associated with early evidence of vascular disease assessed by aortic wall thickness. Prospective studies in larger populations including other inflammatory diseases are warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AMJ, Kastelein JJP, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207.CrossRef Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AMJ, Kastelein JJP, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207.CrossRef
2.
Zurück zum Zitat Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31.CrossRef Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31.CrossRef
3.
Zurück zum Zitat Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557–65.CrossRef Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557–65.CrossRef
4.
Zurück zum Zitat Harrington RA. Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377(12):1197–8.CrossRef Harrington RA. Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377(12):1197–8.CrossRef
5.
Zurück zum Zitat Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, et al. Unraveling vascular inflammation: from immunology to imaging. J Am Coll Cardiol. 2017;70(11):1403–12.CrossRef Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, et al. Unraveling vascular inflammation: from immunology to imaging. J Am Coll Cardiol. 2017;70(11):1403–12.CrossRef
6.
Zurück zum Zitat Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging. 2013;6(12):1250–9.CrossRef Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging. 2013;6(12):1250–9.CrossRef
7.
Zurück zum Zitat Figueroa AL, Takx RAP, MacNabb MH, Abdelbaky A, Lavender ZR, Kaplan RS, et al. Relationship between measures of adiposity, arterial inflammation, and subsequent cardiovascular events. Circ: Cardiovasc Imaging. 2016;9(4). Figueroa AL, Takx RAP, MacNabb MH, Abdelbaky A, Lavender ZR, Kaplan RS, et al. Relationship between measures of adiposity, arterial inflammation, and subsequent cardiovascular events. Circ: Cardiovasc Imaging. 2016;9(4).
8.
Zurück zum Zitat Vaidya K, Arnott C, Martínez GJ, Ng B, McCormack S, Sullivan DR, et al. Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study. JACC Cardiovasc Imaging. 2018;11(2, Part 2):305–16.CrossRef Vaidya K, Arnott C, Martínez GJ, Ng B, McCormack S, Sullivan DR, et al. Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study. JACC Cardiovasc Imaging. 2018;11(2, Part 2):305–16.CrossRef
9.
Zurück zum Zitat Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA, et al. Association between aortic vascular inflammation and coronary artery plaque characteristics in Psoriasis. JAMA Cardiol. 2018;3(10):949–56.CrossRef Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA, et al. Association between aortic vascular inflammation and coronary artery plaque characteristics in Psoriasis. JAMA Cardiol. 2018;3(10):949–56.CrossRef
10.
Zurück zum Zitat Dey AK, Joshi AA, Chaturvedi A, et al. Association between skin and aortic vascular inflammation in patients with psoriasis: a case-cohort study using positron emission tomography/computed tomography. JAMA Cardiol. 2017;2(9):1013–8.CrossRef Dey AK, Joshi AA, Chaturvedi A, et al. Association between skin and aortic vascular inflammation in patients with psoriasis: a case-cohort study using positron emission tomography/computed tomography. JAMA Cardiol. 2017;2(9):1013–8.CrossRef
11.
Zurück zum Zitat Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. J Am Coll Cardiol. 2013;62(10):909–17.CrossRef Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. J Am Coll Cardiol. 2013;62(10):909–17.CrossRef
12.
Zurück zum Zitat Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-f] fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT). J Vis Exp: JoVE. 2012;63:e3777-e. Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-f] fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT). J Vis Exp: JoVE. 2012;63:e3777-e.
13.
Zurück zum Zitat Naredo E, Möller I, Corrales A, Bong DA, Cobo-Ibáñez T, Corominas H, et al. Automated radiofrequency-based US measurement of common carotid intima–media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs. Rheumatology. 2013;52(2):376–81.CrossRef Naredo E, Möller I, Corrales A, Bong DA, Cobo-Ibáñez T, Corominas H, et al. Automated radiofrequency-based US measurement of common carotid intima–media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs. Rheumatology. 2013;52(2):376–81.CrossRef
14.
Zurück zum Zitat Kisiel B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, Bachta A, Tlustochowicz M, et al. Methotrexate, cyclosporine a, and biologics protect against atherosclerosis in rheumatoid arthritis. J Immunol Res. 2015;2015:8.CrossRef Kisiel B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, Bachta A, Tlustochowicz M, et al. Methotrexate, cyclosporine a, and biologics protect against atherosclerosis in rheumatoid arthritis. J Immunol Res. 2015;2015:8.CrossRef
15.
Zurück zum Zitat Abolmaali N, Langenfeld M, Krahforst R, Schick C, Thalhammer A, Schmitt J, et al. Vessel wall MRI of the thoracic aorta: correlation to histology and transesophageal ultrasound. Preliminary results. Rofo. 2002;174(5):568–72.CrossRef Abolmaali N, Langenfeld M, Krahforst R, Schick C, Thalhammer A, Schmitt J, et al. Vessel wall MRI of the thoracic aorta: correlation to histology and transesophageal ultrasound. Preliminary results. Rofo. 2002;174(5):568–72.CrossRef
16.
Zurück zum Zitat Maroules CD, Rosero E, Ayers C, Peshock RM, Khera A. Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas heart study. Radiology. 2013;269(1):84–91.CrossRef Maroules CD, Rosero E, Ayers C, Peshock RM, Khera A. Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas heart study. Radiology. 2013;269(1):84–91.CrossRef
17.
Zurück zum Zitat Malayeri AA, Natori S, Bahrami H, Bertoni AG, Kronmal R, Lima JAC, et al. Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the multi-ethnic study of atherosclerosis [MESA]). Am J Cardiol. 2008;102(4):491–6.CrossRef Malayeri AA, Natori S, Bahrami H, Bertoni AG, Kronmal R, Lima JAC, et al. Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the multi-ethnic study of atherosclerosis [MESA]). Am J Cardiol. 2008;102(4):491–6.CrossRef
18.
Zurück zum Zitat Rosero EB, Peshock RM, Khera A, Clagett P, Lo H, Timaran CH. Sex, race, and age distributions of mean aortic wall thickness in a multiethnic population-based sample. J Vasc Surg. 2011;53(4):950–7.CrossRef Rosero EB, Peshock RM, Khera A, Clagett P, Lo H, Timaran CH. Sex, race, and age distributions of mean aortic wall thickness in a multiethnic population-based sample. J Vasc Surg. 2011;53(4):950–7.CrossRef
19.
Zurück zum Zitat Gupta S, Berry JD, Ayers CR, Peshock RM, Khera A, de Lemos JA, et al. Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease: the Dallas heart study. JACC Cardiovasc Imaging. 2010;3(6):605–13.CrossRef Gupta S, Berry JD, Ayers CR, Peshock RM, Khera A, de Lemos JA, et al. Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease: the Dallas heart study. JACC Cardiovasc Imaging. 2010;3(6):605–13.CrossRef
20.
Zurück zum Zitat Liu C-Y, Chen D, Bluemke DA, Wu CO, Teixido-Tura G, Chugh A, et al. Evolution of aortic wall thickness and stiffness with atherosclerosis: long-term follow up from the multi-ethnic study of atherosclerosis (MESA). Hypertension. 2015;65(5):1015–9.CrossRef Liu C-Y, Chen D, Bluemke DA, Wu CO, Teixido-Tura G, Chugh A, et al. Evolution of aortic wall thickness and stiffness with atherosclerosis: long-term follow up from the multi-ethnic study of atherosclerosis (MESA). Hypertension. 2015;65(5):1015–9.CrossRef
21.
Zurück zum Zitat Li AE, Kamel I, Rando F, Anderson M, Kumbasar B, Lima JAC, et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. Am J Roentgenol. 2004;182(3):593–7.CrossRef Li AE, Kamel I, Rando F, Anderson M, Kumbasar B, Lima JAC, et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. Am J Roentgenol. 2004;182(3):593–7.CrossRef
22.
Zurück zum Zitat Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the United Kingdom. Br J Dermatol. 2010;163(3):586–92.CrossRef Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the United Kingdom. Br J Dermatol. 2010;163(3):586–92.CrossRef
23.
Zurück zum Zitat Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J. 2010;31(8):1000–6.CrossRef Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J. 2010;31(8):1000–6.CrossRef
24.
Zurück zum Zitat Naik Haley B, Natarajan B, Stansky E, Ahlman Mark A, Teague H, Salahuddin T, et al. Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective observational study. Arterioscler Thromb Vasc Biol. 2015;35(12):2667–76.CrossRef Naik Haley B, Natarajan B, Stansky E, Ahlman Mark A, Teague H, Salahuddin T, et al. Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective observational study. Arterioscler Thromb Vasc Biol. 2015;35(12):2667–76.CrossRef
25.
Zurück zum Zitat Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–8.CrossRef Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–8.CrossRef
26.
Zurück zum Zitat Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(suppl 2):ii65–i8.PubMedPubMedCentral Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(suppl 2):ii65–i8.PubMedPubMedCentral
27.
Zurück zum Zitat Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–43.CrossRef Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–43.CrossRef
28.
Zurück zum Zitat Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013;166(4):622–8 e1.CrossRef Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013;166(4):622–8 e1.CrossRef
29.
Zurück zum Zitat Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105(23):2708–11.CrossRef Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105(23):2708–11.CrossRef
30.
Zurück zum Zitat Yu Y, Sheth N, Krishnamoorthy P, Saboury B, Raper A, Baer A, et al. Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study. Am J Cardiovasc Dis. 2012;2(4):285–92.PubMedPubMedCentral Yu Y, Sheth N, Krishnamoorthy P, Saboury B, Raper A, Baer A, et al. Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study. Am J Cardiovasc Dis. 2012;2(4):285–92.PubMedPubMedCentral
31.
Zurück zum Zitat Hayashida T, Sueyoshi E, Sakamoto I, Uetani M, Chiba K. PET features of aortic diseases. Am J Roentgenol. 2010;195(1):229–33.CrossRef Hayashida T, Sueyoshi E, Sakamoto I, Uetani M, Chiba K. PET features of aortic diseases. Am J Roentgenol. 2010;195(1):229–33.CrossRef
32.
Zurück zum Zitat Joly L, Djaballah W, Koehl G, Mandry D, Dolivet G, Marie PY, et al. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging. 2009;36(6):979–85.CrossRef Joly L, Djaballah W, Koehl G, Mandry D, Dolivet G, Marie PY, et al. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging. 2009;36(6):979–85.CrossRef
33.
Zurück zum Zitat Huet P, Burg S, Le Guludec D, Hyafil F, Buvat I. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. J Nucl Med. 2015;56(4):552–9.CrossRef Huet P, Burg S, Le Guludec D, Hyafil F, Buvat I. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. J Nucl Med. 2015;56(4):552–9.CrossRef
Metadaten
Titel
Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study
verfasst von
Jacob W. Groenendyk
Parag Shukla
Amit K. Dey
Youssef A. Elnabawi
Milena Aksentijevich
Harry Choi
Leonard D. Genovese
Charlotte L. Harrington
Balaji Natarajan
Aditya Goyal
Aarthi S. Reddy
Justin Rodante
Mohammad Tarek Kabbany
Ahmed Sadek
Mina Al Najafi
Martin P. Playford
Aditya A. Joshi
Mark A. Ahlman
Joel M. Gelfand
David A. Bluemke
Nehal N. Mehta
Publikationsdatum
05.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04454-w

Weitere Artikel der Ausgabe 12/2019

European Journal of Nuclear Medicine and Molecular Imaging 12/2019 Zur Ausgabe